Histone Therapeutics (Histone Tx) is a Seattle-based biotech company developing novel epigenetic editing technologies to treat disease by directly controlling gene regulation. Its first-in-class modul ...

Hopstem aims to develop innovative iPSC cell therapy for global CNS patients. The potential RMAT, BIC and FIC hNPC01 injection received IND clearance from FDA and NMPA, completed Phase I study for chr ...

We have unique device called cell stamping processor to introduce biological high molecules like proteins, mitochondria and exosome as well as genes into cells by nano-needle injection.  This sophisti ...

It takes 72 hours to identify a bacterial infection. Three days while a patient waits, a clinician guesses, and resistance spreads. HyperSpectral does it in under 10 minutes — and that's just one vert ...

Health Innovation Capital (HIC) is a pediatric focused venture capital impact fund dedicated to supporting the growth and maturation of best-in-class healthcare solutions that target this patient popu ...

MISSION STATEMENT: The HIV+Hepatitis Policy Institute promotes quality and affordable healthcare for people living with or at risk of HIV, hepatitis, and other serious and chronic health conditions.

HK WinHealth Pharma Group is a leading, fully integrated commercialization platform focused on bringing innovative and specialty therapies to Greater China and Asia‑Pacific. Our strengths span hematol ...

Halia Therapeutics is Leading the Science in novel drug discovery to eliminate chronic inflammation and promote longevity through treatment of neurodegeneration and inflammatory diseases.

Cybin is a late-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options to address the large unmet ...